Companies / Vietnam
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Vietnam Sees Rise In Counterfeit Drugs
April 2006 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Meanwhile, drugmakers in Vietnam have asked for permission to raise the selling price of 125 drug categories, according to local press reports, claming that the rising cost of imported raw materials has impacted production costs. The firms have also requested more capital investment in order to upgrade facilities and build plants meeting Good Manufacturing Practice (GMP) standards.